Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
28 Jan 2022
Historique:
pubmed: 7 1 2022
medline: 12 2 2022
entrez: 6 1 2022
Statut: ppublish

Résumé

Understanding broadly neutralizing sarbecovirus antibody responses is key to developing countermeasures against SARS-CoV-2 variants and future zoonotic sarbecoviruses. We describe the isolation and characterization of a human monoclonal antibody, designated S2K146, that broadly neutralizes viruses belonging to SARS-CoV- and SARS-CoV-2-related sarbecovirus clades which use ACE2 as an entry receptor. Structural and functional studies show that most of the virus residues that directly bind S2K146 are also involved in binding to ACE2. This allows the antibody to potently inhibit receptor attachment. S2K146 protects against SARS-CoV-2 Beta challenge in hamsters and viral passaging experiments reveal a high barrier for emergence of escape mutants, making it a good candidate for clinical development. The conserved ACE2-binding residues present a site of vulnerability that might be leveraged for developing vaccines eliciting broad sarbecovirus immunity.

Identifiants

pubmed: 34990214
doi: 10.1126/science.abm8143
pmc: PMC9400459
mid: NIHMS1830835
doi:

Substances chimiques

Antibodies, Monoclonal 0
Antibodies, Viral 0
Broadly Neutralizing Antibodies 0
Epitopes 0
Receptors, Coronavirus 0
Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0
ACE2 protein, human EC 3.4.17.23
Angiotensin-Converting Enzyme 2 EC 3.4.17.23

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

449-454

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM120553
Pays : United States
Organisme : NIAID NIH HHS
ID : DP1 AI158186
Pays : United States
Organisme : NIH HHS
ID : S10 OD023476
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008268
Pays : United States

Commentaires et corrections

Type : UpdateOf

Références

Science. 2021 Aug 6;373(6555):648-654
pubmed: 34210893
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
pubmed: 20057044
Science. 2021 Dec 24;374(6575):1621-1626
pubmed: 34751595
EBioMedicine. 2021 Jun;68:103403
pubmed: 34049240
Nat Methods. 2020 Dec;17(12):1214-1221
pubmed: 33257830
Cell. 2020 May 14;181(4):894-904.e9
pubmed: 32275855
Nature. 2021 Oct;598(7880):342-347
pubmed: 34464958
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Science. 2021 Aug 27;373(6558):991-998
pubmed: 34214046
Science. 2021 Feb 19;371(6531):850-854
pubmed: 33495308
Structure. 2019 Jan 2;27(1):134-139.e3
pubmed: 30344107
Cell. 2020 Nov 25;183(5):1367-1382.e17
pubmed: 33160446
Cell. 2021 Jun 10;184(12):3086-3108
pubmed: 34087172
Nature. 2020 Jul;583(7815):290-295
pubmed: 32422645
Nat Struct Mol Biol. 2015 Nov;22(11):833-4
pubmed: 26581513
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Cell Host Microbe. 2019 Nov 13;26(5):623-637.e8
pubmed: 31653484
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
Elife. 2016 Sep 26;5:
pubmed: 27669148
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
Science. 2021 Feb 19;371(6531):823-829
pubmed: 33495307
Nature. 2021 Jun;594(7862):253-258
pubmed: 33873199
Science. 2020 Aug 7;369(6504):731-736
pubmed: 32540900
Cell. 2021 Apr 15;184(8):2183-2200.e22
pubmed: 33756110
Nat Methods. 2015 Oct;12(10):943-6
pubmed: 26280328
Science. 2020 Sep 18;369(6510):1501-1505
pubmed: 32703906
IUCrJ. 2019 Jan 01;6(Pt 1):5-17
pubmed: 30713699
Nature. 2021 Sep;597(7874):97-102
pubmed: 34261126
Nature. 2021 Sep;597(7874):103-108
pubmed: 34280951
J Mol Biol. 2003 Oct 31;333(4):721-45
pubmed: 14568533
Nat Commun. 2022 Aug 9;13(1):4380
pubmed: 35945197
Cell Host Microbe. 2020 Sep 9;28(3):445-454.e6
pubmed: 32585135
Nature. 2020 May;581(7807):221-224
pubmed: 32225175
Nat Commun. 2021 Mar 17;12(1):1715
pubmed: 33731724
Cell Rep. 2021 Sep 28;36(13):109760
pubmed: 34534459
Cell Host Microbe. 2020 Sep 9;28(3):475-485.e5
pubmed: 32735849
Nat Microbiol. 2020 Apr;5(4):562-569
pubmed: 32094589
Science. 2021 Sep 03;373(6559):1109-1116
pubmed: 34344823
Nature. 2021 Jun;594(7864):553-559
pubmed: 33971664
Proc Natl Acad Sci U S A. 2017 Oct 17;114(42):11157-11162
pubmed: 29073020
Nature. 2016 Mar 3;531(7592):114-117
pubmed: 26855426
Ultramicroscopy. 2013 Dec;135:24-35
pubmed: 23872039
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Adv Virus Res. 2019;105:93-116
pubmed: 31522710
Science. 2020 Nov 20;370(6519):950-957
pubmed: 32972994
Nature. 2022 Mar;603(7903):913-918
pubmed: 35114688
Cell. 2020 Sep 3;182(5):1295-1310.e20
pubmed: 32841599
Nat Struct Mol Biol. 2021 Jun;28(6):478-486
pubmed: 33981021
Cell Host Microbe. 2021 Jan 13;29(1):44-57.e9
pubmed: 33259788
Sci Transl Med. 2021 Jun 30;13(600):
pubmed: 34103407
Acta Crystallogr D Struct Biol. 2019 Oct 1;75(Pt 10):861-877
pubmed: 31588918
Cell Rep. 2021 Nov 2;37(5):109929
pubmed: 34710354
Cell Rep Med. 2021 Apr 20;2(4):100255
pubmed: 33842902
Elife. 2018 Nov 09;7:
pubmed: 30412051
Nat Commun. 2020 Nov 17;11(1):5838
pubmed: 33203860
Science. 2005 Sep 16;309(5742):1864-8
pubmed: 16166518
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
J Struct Biol. 2005 Jul;151(1):41-60
pubmed: 15890530
J Virol. 2010 Apr;84(7):3210-9
pubmed: 20071581
Cell. 2021 Oct 14;184(21):5432-5447.e16
pubmed: 34619077
Cell. 2020 Nov 12;183(4):1024-1042.e21
pubmed: 32991844
Nat Methods. 2019 Nov;16(11):1146-1152
pubmed: 31591575
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Science. 2021 Mar 25;:
pubmed: 33766944
Nature. 2021 Nov;599(7883):114-119
pubmed: 34488225
Viruses. 2020 May 06;12(5):
pubmed: 32384820
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
Protein Sci. 2018 Jan;27(1):14-25
pubmed: 28710774
Nat Commun. 2021 May 19;12(1):2938
pubmed: 34011939
Cell. 2019 Feb 21;176(5):1026-1039.e15
pubmed: 30712865

Auteurs

Young-Jun Park (YJ)

Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA.

Anna De Marco (A)

Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.

Tyler N Starr (TN)

Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

Zhuoming Liu (Z)

Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA.

Dora Pinto (D)

Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.

Alexandra C Walls (AC)

Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA.

Fabrizia Zatta (F)

Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.

Samantha K Zepeda (SK)

Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.

John E Bowen (JE)

Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.

Kaitlin R Sprouse (KR)

Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.

Anshu Joshi (A)

Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.

Martina Giurdanella (M)

Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.

Barbara Guarino (B)

Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.

Julia Noack (J)

Vir Biotechnology, San Francisco, CA 94158, USA.

Rana Abdelnabi (R)

Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium.

Shi-Yan Caroline Foo (SC)

Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium.

Laura E Rosen (LE)

Vir Biotechnology, San Francisco, CA 94158, USA.

Florian A Lempp (FA)

Vir Biotechnology, San Francisco, CA 94158, USA.

Fabio Benigni (F)

Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.

Gyorgy Snell (G)

Vir Biotechnology, San Francisco, CA 94158, USA.

Johan Neyts (J)

Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium.

Sean P J Whelan (SPJ)

Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA.

Herbert W Virgin (HW)

Vir Biotechnology, San Francisco, CA 94158, USA.
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Jesse D Bloom (JD)

Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA.
Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

Davide Corti (D)

Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.

Matteo Samuele Pizzuto (MS)

Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.

David Veesler (D)

Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH